3,4-DIHYDROISOQUINOLIN-2(1H)-YL COMPOUNDS

The invention provides certain 3,4-dihydroisoquinolin-2(1H)-yl compounds, particularly compounds of formula I, and pharmaceutical compositions thereof. The invention further provides methods of using a compound of formula I to treat cognitive impairment associated with Parkinson's disease or sc...

Full description

Saved in:
Bibliographic Details
Main Authors HAO, JUNLIANG, SCHAUS, JOHN MEHNERT, BEADLE, CHRISTOPHER DAVID, WOLFANGEL, CRAIG DANIEL, KRUSHINSKI JR., JOSEPH HERMAN, COATES, DAVID ANDREW, REINHARD, MATTHEW ROBERT
Format Patent
LanguageEnglish
Published 30.12.2015
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract The invention provides certain 3,4-dihydroisoquinolin-2(1H)-yl compounds, particularly compounds of formula I, and pharmaceutical compositions thereof. The invention further provides methods of using a compound of formula I to treat cognitive impairment associated with Parkinson's disease or schizophrenia.
AbstractList The invention provides certain 3,4-dihydroisoquinolin-2(1H)-yl compounds, particularly compounds of formula I, and pharmaceutical compositions thereof. The invention further provides methods of using a compound of formula I to treat cognitive impairment associated with Parkinson's disease or schizophrenia.
Author COATES, DAVID ANDREW
REINHARD, MATTHEW ROBERT
BEADLE, CHRISTOPHER DAVID
SCHAUS, JOHN MEHNERT
WOLFANGEL, CRAIG DANIEL
KRUSHINSKI JR., JOSEPH HERMAN
HAO, JUNLIANG
Author_xml – fullname: HAO, JUNLIANG
– fullname: SCHAUS, JOHN MEHNERT
– fullname: BEADLE, CHRISTOPHER DAVID
– fullname: WOLFANGEL, CRAIG DANIEL
– fullname: KRUSHINSKI JR., JOSEPH HERMAN
– fullname: COATES, DAVID ANDREW
– fullname: REINHARD, MATTHEW ROBERT
BookMark eNrjYmDJy89L5WTQNNYx0XXx9Ih0CfL3DPYPDPX08_fx9NM10jD00NSN9FFw9vcN8A_1cwnmYWBNS8wpTuWF0twMKm6uIc4euqkF-fGpxQWJyal5qSXxwe6GhkYGhqYGlsaGBoGOxkQqAwDWZic2
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID SG11201509310QA
GroupedDBID EVB
ID FETCH-epo_espacenet_SG11201509310QA3
IEDL.DBID EVB
IngestDate Fri Jul 19 14:40:35 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_SG11201509310QA3
Notes Application Number: SG20151109310Q
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20151230&DB=EPODOC&CC=SG&NR=11201509310QA
ParticipantIDs epo_espacenet_SG11201509310QA
PublicationCentury 2000
PublicationDate 20151230
PublicationDateYYYYMMDD 2015-12-30
PublicationDate_xml – month: 12
  year: 2015
  text: 20151230
  day: 30
PublicationDecade 2010
PublicationYear 2015
RelatedCompanies ELI LILLY AND COMPANY
RelatedCompanies_xml – name: ELI LILLY AND COMPANY
Score 3.0098503
Snippet The invention provides certain 3,4-dihydroisoquinolin-2(1H)-yl compounds, particularly compounds of formula I, and pharmaceutical compositions thereof. The...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title 3,4-DIHYDROISOQUINOLIN-2(1H)-YL COMPOUNDS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20151230&DB=EPODOC&locale=&CC=SG&NR=11201509310QA
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1JT8JAFH5BNOpNUYMLhgNpJHFiaUulh8ZIh9Ia6BQKBk6kHdvEg0ikxr_vm0lxuehtluTNkrzlmzfzDUAjE9khdGXkyUxSYuhmRjpcjwniZTNTDR7zVLJ9BqY3NR5m7VkJXjZvYSRP6IckR0SN4qjvubTXq-9DLCrvVq5vkmdser1zJzZVCnQs3JeuKrRr90JGmaM4jh31lWBsY1ghsL2F0czofgu2RSQtqPZ7j13xMGX106u4B7ATosBlfgildFmBPWfz-VoFdodFzhuLhfqtj6CpXxuE-t6cjpkfsdHUD9jAD4h21fKaZD6oO2wYsmlAo2NouL2J4xEcc_G1xkXU_zVD_QTKCP_TKtQ13TCSDrfUdqKhVbuNTS3OWhpH4GBxK9VOofanqLN_-s9hX9QkeaF6AeX87T2toaPNk0u5PZ9h6XsD
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1bT8IwFD5BNOKbosYbygNZJLFxbGOwh8XICmwKKzBG4IlsdUt8EInM-Pc9bcDLi741bXJ6SU6_87U9XwEqqbgdQigjT2acEEM3U9LkekSQL5upavCIJ1Lt0zfd0HiY1qc5eNnkwkid0A8pjogexdHfM7lfL78Psah8W7m6jZ-x6vWuM7apsmbHAr50VaEtuz1glDmK49hBV_FHNoYVgttbGM0M77dguyEEekX0NGmJxJTlT1Tp7MPOAA0usgPIJYsiFJzN52tF2O2v77yxuHa_1SFU9RuDUM-d0RHzAjYMPZ_1PJ9o1zW3Sma9ssP6Axb6NDiCSqc9dlyCfc6_5jgPur9GqB9DHul_cgJlTTeMuMkttR5ruKs1IlOL0prGkThY3Eq0Uyj9aersn_YrKLjjfm-Ow308hz3RIoUM1QvIZ2_vSQlBN4sv5VJ9AkrxffA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=3%2C4-DIHYDROISOQUINOLIN-2%281H%29-YL+COMPOUNDS&rft.inventor=HAO%2C+JUNLIANG&rft.inventor=SCHAUS%2C+JOHN+MEHNERT&rft.inventor=BEADLE%2C+CHRISTOPHER+DAVID&rft.inventor=WOLFANGEL%2C+CRAIG+DANIEL&rft.inventor=KRUSHINSKI+JR.%2C+JOSEPH+HERMAN&rft.inventor=COATES%2C+DAVID+ANDREW&rft.inventor=REINHARD%2C+MATTHEW+ROBERT&rft.date=2015-12-30&rft.externalDBID=A&rft.externalDocID=SG11201509310QA